Author

Jeffrey E. Kelsey

Observed names: J E Kelsey, JEFFREY E. KELSEY, Jeffrey E Kelsey, Jeffrey E. Kelsey MD, PhD, Jeffrey Kelsey

Observed institutions: Atrium Health Wake Forest Baptist, Janssen (Belgium), Emory University, Pfizer (United States), SUNY Upstate Medical University, University of Michigan, Abbott (United Kingdom), Fukuyama University, Bristol-Myers Squibb (United States)

OpenAlex ID: A5108631433

Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

2003 · Mark S Kramer, Andrew Winokur, et al. · Neuropsychopharmacology · 254

The Neural Correlates of Social Anxiety Disorder and Response to Pharmacotherapy

2006 · Clinton D Kilts, Jeffrey E Kelsey, et al. · Neuropsychopharmacology · 128

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial

2004 · Murray B. Stein, Mark H. Pollack, et al. · Psychopharmacology · 110

Venlafaxine in social phobia.

1995 · J E Kelsey · PubMed · 85

Removing the superior colliculus silences eye movements normally evoked from stimulation of the parietal and occipital eye fields

1983 · E. Gregory Keating, Stephen G. Gooley, et al. · Brain Research · 83

Pretranslational and Posttranslational Mechanisms for Regulatingβ-Endorphin- Adrenocorticotropin of the Anterior Pituitary Lobe*

1986 · HIROHITO SHIOMI, STANLEY J. WATSON, et al. · Endocrinology · 62

Erratum: The Neural Correlates of Social Anxiety Disorder and Response to Pharmacotherapy

2006 · Clinton D Kilts, Jeffrey E Kelsey, et al. · Neuropsychopharmacology · 59

PDF

Dose-Response Relationship With Venlafaxine

1996 · JEFFREY E. KELSEY · Journal of Clinical Psychopharmacology · 48

Efficacy, safety, and tolerability of venlafaxine XR in generalized anxiety disorder

2000 · Jeffrey E. Kelsey · Depression and Anxiety · 18

Clinician perspective on achieving and maintaining remission in depression.

2001 · J E Kelsey · PubMed · 15

An Evaluation of a Computer Assisted Telephone Interview for Screening for Mental Disorders among Primary Care Patients

1999 · Andrew C. Leon, Jeffrey E. Kelsey, et al. · The Journal of Nervous and Mental Disease · 12

Principles of Psychopharmacology for Mental Health Professionals

2005 · Jeffrey E. Kelsey, D. Jeffrey Newport, et al. · Wiley eBooks · 11

Achieving remission in major depressive disorder: the first step to long-term recovery.

2004 · Jeffrey E Kelsey · PubMed · 10

Introduction and Overview

2005 · Jeffrey E. Kelsey MD, PhD, D. Jeffrey Newport MD, et al. · Wiley eBooks · 7

Switching Drug Class After Initial SSRI Failure

1997 · Jeffrey E. Kelsey · The Journal of Clinical Psychiatry · 7

PDF

OPIOID PEPTIDES AND VASOPRESSIN The Application of In Situ Hybridization to Studies of the Hypothalamus and Pituitary

1986 · Thomas G. Sherman, Jeffrey E. Kelsey, et al. · 6

Traumatic Brain Injury

2005 · Jeffrey E. Kelsey MD, PhD, D. Jeffrey Newport MD, et al. · Wiley eBooks · 5

Opioid Peptides and Vasopressin

1986 · Thomas G. Sherman, Jeffrey E. Kelsey, et al. · Springer eBooks · 4

Alzheimer's Disease and Other Dementias

2005 · Jeffrey E. Kelsey MD, PhD, D. Jeffrey Newport MD, et al. · Wiley eBooks · 3

Attention Deficit–Hyperactivity Disorder

2005 · Jeffrey E. Kelsey MD, PhD, D. Jeffrey Newport MD, et al. · Wiley eBooks · 2

Regulation of Beta-Endorphin Biosynthesis in the Brain: Different Effects of Morphine Pelleting and Repeated Stress

1991 · David M. Bronstein, Huda Akil, et al. · PsycEXTRA Dataset · 2

Basics of Psychopharmacology

2005 · Jeffrey E. Kelsey MD, PhD, D. Jeffrey Newport MD, et al. · Wiley eBooks · 1

Treatment of Chronic Depression

1996 · Jeffrey E. Kelsey · JAMA · 1

Dose-Response Relationship With Venlafaxine: Commentary

1996 · JEFFREY E. KELSEY · Journal of Clinical Psychopharmacology · 1

Social Anxiety: An Often Silent Disorder

2025 · Jeffrey E. Kelsey, MD, et al. · Psychopharmacology Bulletin

Works count: 36

Citation count: 934

H-index: 11

I10-index: 13